89 related articles for article (PubMed ID: 23268288)
1. CCL22 16C/a genetic variation is not associated with breast carcinoma in Southern Iranian population.
Erfani N; Moghaddasi-Sani F; Razmkhah M; Haghshenas MR; Talei A; Ghaderi A
Iran J Immunol; 2012 Dec; 9(4):226-33. PubMed ID: 23268288
[TBL] [Abstract][Full Text] [Related]
2. Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.
Jafarzadeh A; Fooladseresht H; Minaee K; Bazrafshani MR; Khosravimashizi A; Nemati M; Mohammadizadeh M; Mohammadi MM; Ghaderi A
Tumour Biol; 2015 Feb; 36(2):1163-71. PubMed ID: 25722218
[TBL] [Abstract][Full Text] [Related]
3. CCR4 C1014T and CCL22 C16A genetic variations in the Iranian patients with colorectal adenocarcinoma.
Erfani N; Ahrari S; Ahrari I; Hosseini SV
Iran J Allergy Asthma Immunol; 2014 Dec; 13(6):440-6. PubMed ID: 25148803
[TBL] [Abstract][Full Text] [Related]
4. CCL22 and CCR4 Gene Polymorphisms in Myocardial Infarction: Risk Assessment of rs4359426 and rs2228428 in Iranian Population.
Noori F; Naeimi S; Zibaeenezhad MJ; Gharemirshamlu FR
Clin Lab; 2018 Jun; 64(6):907-913. PubMed ID: 29945324
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma.
Wang G; Yu D; Tan W; Zhao D; Wu C; Lin D
Cancer; 2009 Jun; 115(11):2430-7. PubMed ID: 19298002
[TBL] [Abstract][Full Text] [Related]
7. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
8. Strong association of CTLA-4 variation (CT60A/G) and CTLA-4 haplotypes with predisposition of Iranians to head and neck cancer.
Erfani N; Haghshenas MR; Hoseini MA; Hashemi SB; Khademi B; Ghaderi A
Iran J Immunol; 2012 Sep; 9(3):188-98. PubMed ID: 23023383
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.
Galimberti D; Scalabrini D; Fenoglio C; De Riz M; Comi C; Venturelli E; Cortini F; Piola M; Leone M; Dianzani U; D'Alfonso S; Monaco F; Bresolin N; Scarpini E
J Neurol Sci; 2008 Apr; 267(1-2):86-90. PubMed ID: 17967467
[TBL] [Abstract][Full Text] [Related]
10. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
11. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer.
Razmkhah M; Doroudchi M; Ghayumi SM; Erfani N; Ghaderi A
Lung Cancer; 2005 Sep; 49(3):311-5. PubMed ID: 15955592
[TBL] [Abstract][Full Text] [Related]
13. Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease.
Safa A; Rashidinejad HR; Khalili M; Dabiri S; Nemati M; Mohammadi MM; Jafarzadeh A
Cytokine; 2016 Jul; 83():147-157. PubMed ID: 27152707
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer.
Erfani N; Nedaei Ahmadi AS; Ghayumi MA; Mojtahedi Z
Iran J Med Sci; 2014 Jul; 39(4):367-73. PubMed ID: 25031489
[TBL] [Abstract][Full Text] [Related]
15. Stromal cell derived factor-1 genetic variation at locus 801 in patients with myasthenia gravis.
Yousefipour GA; Haghshenas MR; Yahyazadeh S; Erfani N
Iran J Immunol; 2011 Jun; 8(2):90-5. PubMed ID: 21705836
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
[TBL] [Abstract][Full Text] [Related]
17. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
Yuan YD; Zhao MX; Yu J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
[TBL] [Abstract][Full Text] [Related]
18. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.
Kamali-Sarvestani E; Talei AR; Merat A
Cancer Lett; 2004 Nov; 215(1):83-7. PubMed ID: 15374636
[TBL] [Abstract][Full Text] [Related]
19. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.
Akadam-Teker B; Kurnaz O; Coskunpinar E; Daglar-Aday A; Kucukhuseyin O; Cakmak HA; Teker E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
Gene; 2013 Oct; 528(2):93-8. PubMed ID: 23933271
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
